BRAF and melanoma: Whole exome sequencing of drug resistant tumors revealed the recurrent copy number gain of BRAF V600E at a frequency of 19%-28% as a common resistant mechanism to RAFi in melanoma, which hyperactivates ERK signaling independent of CRAF 80, 83-85.